Promising new drug shows hope for fatty liver disease
Disease control
Completed
This study tested a new drug called pemvidutide in 212 adults with NASH, a serious fatty liver disease that can lead to liver damage. The goal was to see if the drug could reduce liver fat and scarring without making the disease worse. Participants received either the drug or a p…
Phase: PHASE2 • Sponsor: Altimmune, Inc. • Aim: Disease control
Last updated May 12, 2026 13:42 UTC